Can you still buy 7-OH? — Status board, updated October 6, 2026

  • Concentrated 7-OH tablets and powders: No. Sales ended industry-wide in September 2026. Favor’d Alkz sold its final 7-OH inventory on September 24, 2026, and does not sell concentrated 7-OH in any form.
  • Naturally occurring 7-OH in whole kratom leaf: Never left. 7-OH is a trace alkaloid the kratom leaf itself produces — typically about 2% or less of the leaf’s alkaloid fraction — and natural leaf was never the target of the federal action.
  • Full-spectrum kratom tablets & capsules: Yes — shipping today. Our full-spectrum lineup ships to 27 states, with lot-matched ISO/IEC 17025 lab testing.

“Can you still buy 7-OH?” is really three different questions wearing one trench coat, and the honest answer depends entirely on which one you are asking. If you mean the concentrated tablets and powders that defined the category through mid-2026 — no, that era ended in September. If you mean the molecule itself, the one the kratom leaf has always produced in trace amounts — that never went anywhere. And if you mean “is there anything I can actually order today,” the answer is yes, with real conditions attached. This page is the dated, plain-English status board for all three, written by a company that sold concentrated 7-OH until the last compliant day and then stopped.

What exactly ended in September 2026 — and why

The concentrated 7-OH category wound down because of two separate DEA dockets, and the distinction between them matters.

DEA-1570 is the 7-OH docket. Published in the Federal Register on July 6, 2026, it proposed placing 7-hydroxymitragynine above specific thresholds into Schedule I on a temporary basis: more than 1.00 mg of 7-OH per article for a finished product, or more than 0.050% 7-OH by dry weight for plant material. Every concentrated tablet and powder on the market sat far above those lines — which is why, as the process advanced through the summer, sellers across the category ended sales rather than operate into an uncertain effective date. Favor’d Alkz processed its final 7-OH order on September 24, 2026. The final rule on DEA-1570 is still pending as of this writing: the proposed thresholds define the shape of the action, but the final order had not been published when this page was last updated, and we will not state that it has until it appears in the Federal Register.

DEA-1644 is the analogue docket, and unlike DEA-1570 it is in force. It placed mitragynine pseudoindoxyl, MGM-15, and MGM-16 into temporary Schedule I with zero thresholds, effective August 26, 2026. Favor’d Alkz sells none of those compounds; products containing them were withdrawn before the order took effect and remaining stock was destroyed.

What neither docket named: mitragynine itself and natural kratom leaf, both of which remain unscheduled federally. The 0.050% dry-weight line in DEA-1570 was drawn precisely because natural leaf sits well below it.

What “still buying 7-OH” actually means now

Here is the part most of the search results get wrong: 7-OH did not vanish from the world in September 2026, because 7-OH was never only a product — it is a molecule the kratom tree makes on its own. 7-hydroxymitragynine occurs naturally in kratom leaf as a trace alkaloid, typically around 2% or less of the leaf’s alkaloid fraction, a figure documented in the peer-reviewed literature and acknowledged by the FDA’s own 7-OH page. It is chemically the same molecule as the isolate that filled concentrated tablets — but categorically different in quantity, and quantity is exactly what the proposed federal thresholds measure.

So when a full-spectrum kratom product contains 7-OH today, it contains it the way the leaf does: as one trace member of a much larger alkaloid family. Peer-reviewed work has identified at least 54 alkaloids in Mitragyna speciosa, with mitragynine dominant and 7-OH a minor constituent. Our own lab data shows what that looks like in a finished product. The ISO/IEC 17025 certificate for our Nature’s Organix Blueberry tablet reports 1.721 mg of naturally occurring 7-OH within 307.008 mg of total measured alkaloids — roughly 0.56% of the alkaloid fraction. Compare that to the concentrated tablets of early 2026, which carried tens of milligrams of isolated 7-OH per unit, and the difference between “buying 7-OH” then and now becomes concrete: same molecule, different universe of quantity.

That is the precise sense in which you can still “buy 7-OH” in October 2026: not as an isolate, not above the proposed thresholds, but as the trace alkaloid it has always been inside the leaf’s full profile — measured, documented, and reported lot by lot.

What ships today

Our current catalog is built entirely on that full-spectrum basis — every alkaloid in the proportions the leaf produced, verified by an accredited third-party lab:

The whole lineup lives on the tablets collection. Every product is lab-tested under ISO/IEC 17025, our lab panel quantifies nine separate alkaloid analytes per lot, and the DEA-1644 compounds — mitragynine pseudoindoxyl, MGM-15, MGM-16 — are routinely reported below detection limits in our products, because we do not use them. Certificates are available by email.

Check your state before you order

Federal status is only half the map. Many states regulate kratom through their own Kratom Consumer Protection Act frameworks, several of which cap 7-OH content as a percentage of total alkaloids — and those caps apply regardless of what the DEA does next. That is why our full-spectrum products ship to 27 states rather than 50, and why the first step before ordering is the same for everyone: check your state on our Kratom Regulation Map. It is the live, state-by-state record of where we ship and why, and it is updated as state rules move.

Our update promise: this page is reviewed monthly, and immediately if DEA-1570’s final rule publishes. The date stamp in the status box at the top is the single source of truth for how current this page is — if the stamp is old, trust the Federal Register record over anything written below it.

Frequently asked questions

Can I still buy concentrated 7-OH anywhere legally?

Not from us, and as far as we can verify, not from the legitimate market: concentrated 7-OH sales ended industry-wide in September 2026 while the DEA-1570 final rule remained pending. Favor’d Alkz ended all concentrated 7-OH sales on September 24, 2026. We do not track other companies’ order books and cannot certify what any individual seller is doing — but anything sold today as a high-milligram 7-OH isolate would sit far above the thresholds the DEA has proposed, and we would treat such a listing with caution.

Is the 7-OH in kratom leaf the same molecule as the banned concentrates?

Chemically, yes — 7-hydroxymitragynine is 7-hydroxymitragynine. The difference is quantity, which is exactly what the proposed federal thresholds measure. Natural leaf carries 7-OH as a trace alkaloid, typically about 2% or less of the alkaloid fraction, while the concentrated products of early 2026 contained tens of milligrams of isolate per tablet. Our Blueberry tablet COA, for example, reports 1.721 mg of naturally occurring 7-OH within 307 mg of total measured alkaloids.

Will the DEA’s final rule change this page?

If it changes anything, yes — immediately. The DEA-1570 final rule is still pending as of October 6, 2026. When it publishes, we will update the status box at the top of this page, the FAQ answers, and our state shipping map the same week. The date stamp in the status box tells you exactly how current the page is.

Which states can order full-spectrum kratom tablets right now?

We currently ship full-spectrum tablets and capsules to 27 states. State kratom rules differ — many operate under Kratom Consumer Protection Act caps — and they change, so rather than reprint a list that can go stale, we maintain the live answer on our Kratom Regulation Map. Enter your state there for the current status. All products are for adults 21 and older, where legal.

Research & sources: kratom leaf chemistry and 7-OH facts in this article are drawn from peer-reviewed literature and primary regulatory sources.

This article is provided for informational and educational purposes only. It is not medical, legal, or financial advice, and nothing here should be read as a claim about the effects of any product. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

For adults 21+ only. Check your state and local laws before purchasing.